Oppenheimer analyst Leland Gershell downgraded Clene, Inc. (NASDAQ: CLNN) from Outperform to Perform.The analyst commented, "Top-line Healey ALS Platform trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE